Risk factors, prognostic factors, and nomograms for synchronous brain metastases of solid tumors: a population-based study

Lamba N, Wen PY, Aizer AA (2021) Epidemiology of brain metastases and leptomeningeal disease. Neuro Oncol 23:1447–1456. https://doi.org/10.1093/neuonc/noab101

Article  PubMed  PubMed Central  Google Scholar 

Nayak L, Lee EQ, Wen PY (2012) Epidemiology of brain metastases. Curr Oncol Rep 14:48–54. https://doi.org/10.1007/s11912-011-0203-y

Article  PubMed  Google Scholar 

Achrol AS, Rennert RC, Anders C et al (2019) Brain metastases. Nat Reviews Disease Primers 5. https://doi.org/10.1038/s41572-018-0055-y

Che W, Liu J, Fu T et al (2022) Recent trends in Synchronous Brain Metastasis incidence and mortality in the United States: ten-year Multicenter Experience. Curr Oncol 29:8374–8389. https://doi.org/10.3390/curroncol29110660

Article  PubMed  PubMed Central  Google Scholar 

Ruste V, Sunyach MP, Tanguy R et al (2021) Synchronous brain metastases as a poor prognosis factor in clear cell renal carcinoma: a strong argument for systematic brain screening. J Neurooncol 153:133–141. https://doi.org/10.1007/s11060-021-03751-5

Article  CAS  PubMed  Google Scholar 

Chen J, Yang H, Zhao C et al (2023) Mutational signatures of synchronous and metachronous brain metastases from lung adenocarcinoma. Experimental Hematol Oncol 12. https://doi.org/10.1186/s40164-023-00418-x

Geisler JP, Geisler HE, Wiemann MC et al (1999) p53 expression as a prognostic indicator of 5-year survival in endometrial cancer. Gynecol Oncol 74:468–471. https://doi.org/10.1006/gyno.1999.5482

Article  CAS  PubMed  Google Scholar 

Cortes JE, Kim DW, Pinilla-Ibarz J et al (2018) Ponatinib efficacy and safety in Philadelphia chromosome-positive leukemia: final 5-year results of the phase 2 PACE trial. Blood 132:393–404. https://doi.org/10.1182/blood-2016-09-739086

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shen H, Deng G, Chen Q et al (2021) The incidence, risk factors and predictive nomograms for early death of lung cancer with synchronous brain metastasis: a retrospective study in the SEER database. BMC Cancer 21:825. https://doi.org/10.1186/s12885-021-08490-4

Article  CAS  PubMed  PubMed Central  Google Scholar 

Che W-Q, Li Y-J, Tsang C-K et al (2023) How to use the Surveillance, Epidemiology, and end results (SEER) data: research design and methodology. Military Med Res 10. https://doi.org/10.1186/s40779-023-00488-2

Wu J, Zhang H, Li L et al (2020) A nomogram for predicting overall survival in patients with low-grade endometrial stromal sarcoma: a population-based analysis. Cancer Commun (London England) 40:301–312. https://doi.org/10.1002/cac2.12067

Article  Google Scholar 

Fitzgerald M, Saville BR, Lewis RJ (2015) Decision curve analysis. JAMA 313:409–410. https://doi.org/10.1001/jama.2015.37

Article  CAS  PubMed  Google Scholar 

Song W, Lv CG, Miao DL et al (2018) Development and validation of a nomogram for predicting survival in patients with gastrointestinal stromal tumours. Eur J Surg Oncol 44:1657–1665. https://doi.org/10.1016/j.ejso.2018.07.004

Article  PubMed  Google Scholar 

Lin NU, Lee EQ, Aoyama H et al (2015) Response assessment criteria for brain metastases: proposal from the RANO group. Lancet Oncol 16:e270–e278. https://doi.org/10.1016/s1470-2045(15)70057-4

Article  PubMed  Google Scholar 

Davis FG, Dolecek TA, McCarthy BJ et al (2012) Toward determining the lifetime occurrence of metastatic brain tumors estimated from 2007 United States cancer incidence data. Neuro Oncol 14:1171–1177. https://doi.org/10.1093/neuonc/nos152

Article  PubMed  PubMed Central  Google Scholar 

Parida PK, Marquez-Palencia M, Nair V et al (2022) Metabolic diversity within breast cancer brain-tropic cells determines metastatic fitness. Cell Metabol 34:90–105e7. https://doi.org/10.1016/j.cmet.2021.12.001

Article  CAS  Google Scholar 

Ascha MS, Ostrom QT, Wright J et al (2019) Lifetime Occurrence of Brain Metastases Arising from Lung, Breast, and Skin Cancers in the Elderly: A SEER-Medicare Study. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 28: 917–925. https://doi.org/10.1158/1055-9965.Epi-18-1116

Wang M, Wu Q, Zhang J et al (2021) Prognostic impacts of extracranial metastasis on non-small cell lung cancer with brain metastasis: a retrospective study based on surveillance, epidemiology, and end results database. Cancer Med 10:471–482. https://doi.org/10.1002/cam4.3562

Article  CAS  PubMed  Google Scholar 

Cagney DN, Martin AM, Catalano PJ et al (2017) Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy: a population-based study. Neuro Oncol 19:1511–1521. https://doi.org/10.1093/neuonc/nox077

Article  PubMed  PubMed Central  Google Scholar 

Kumar SK, Dispenzieri A, Lacy MQ et al (2014) Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients. Leukemia 28:1122–1128. https://doi.org/10.1038/leu.2013.313

Article  CAS  PubMed  Google Scholar 

McQuilten Z, Wellard C, Moore E et al (2022) Predictors of early mortality in multiple myeloma: results from the Australian and New Zealand Myeloma and related diseases Registry (MRDR). Br J Haematol 198:830–837. https://doi.org/10.1111/bjh.18324

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kouka M, Buentzel J, Kaftan H et al (2022) Early mortality among patients with Head and Neck Cancer diagnosed in Thuringia, Germany, between 1996 and 2016-A Population-based study. Cancers 14. https://doi.org/10.3390/cancers14133099

Li H, Abbas KS, Abdelazeem B et al (2022) A predictive nomogram for early death in Pheochromocytoma and Paraganglioma. Front Oncol 12:770958. https://doi.org/10.3389/fonc.2022.770958

Article  PubMed  PubMed Central  Google Scholar 

Suh JH, Kotecha R, Chao ST et al (2020) Current approaches to the management of brain metastases. Nat Rev Clin Oncol 17:279–299. https://doi.org/10.1038/s41571-019-0320-3

Article  PubMed  Google Scholar 

Lyu X, Luo B (2021) Prognostic factors and survival prediction in HER2-positive breast cancer with bone metastases: a retrospective cohort study. Cancer Med 10:8114–8126. https://doi.org/10.1002/cam4.4326

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xiong Y, Cao H, Zhang Y et al (2019) Nomogram-predicted survival of breast Cancer brain metastasis: a SEER-Based Population Study. World Neurosurg 128:e823–e834. https://doi.org/10.1016/j.wneu.2019.04.262

Article  PubMed  Google Scholar 

Comments (0)

No login
gif